Morgan Stanley Initiates Coverage on Mindray Medical (MR) with an Overweight
More News related to MR
- Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
- Piper Jaffray Maintains a 'Neutral' on Mindray Medical (MR); Raises Prices Target & 2009 Estimates
- Goldman Sachs Downgrades Mindray Medical (MR) to Neutral
- After-Hours Movers 5/11: STEC, VRNM, MBI, WINN, MTXX, BCON Higher; RST, F, MR, TA Lower
- Mindray Medical (MR) Reports Mixed Q1 Results
Morgan Stanley initiates coverage on Mindray Medical (NYSE: MR) with an Overweight. Price target $50.
Mindray Medical International Limited is developer, manufacturer and marketer of medical devices in China.
Related Categories
New CoverageStocks Mentioned
+0.60Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
